Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,835,082 | $5,433,260 | $3,294,268 | $3,230,788 |
| - Cash | $2,148,865 | $2,598,942 | $2,236,555 | $1,527,186 |
| + Debt | $686,294 | $299,944 | $299,749 | $299,555 |
| Enterprise Value | $3,372,511 | $3,134,262 | $1,357,462 | $2,003,157 |
| Revenue | $2,985,984 | $2,863,945 | $3,046,263 | $2,392,813 |
| % Growth | 4.3% | -6% | 27.3% | – |
| Gross Profit | $2,985,984 | $2,863,945 | $3,046,263 | $2,392,813 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$125,122 | -$220,719 | $300,935 | -$138,430 |
| % Margin | -4.2% | -7.7% | 9.9% | -5.8% |
| Net Income | -$137,450 | -$228,361 | $275,271 | -$153,547 |
| % Margin | -4.6% | -8% | 9% | -6.4% |
| EPS Diluted | -0.53 | -0.89 | 0.92 | -0.62 |
| % Growth | 40.4% | -196.7% | 248.4% | – |
| Operating Cash Flow | -$964,658 | $509,067 | $878,542 | $346,820 |
| Capital Expenditures | -$9,007 | -$9,277 | -$9,026 | -$6,819 |
| Free Cash Flow | -$973,665 | $499,790 | $869,516 | $340,001 |